Surgery Partners, Inc.
SGRYHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeSurgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. Valued at $2.09B, SGRY is a mid-cap name in its sector. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Market Cap
$2.09B
Beta
1.89
P/E (TTM)
—
P/E (Fwd)
24.44
EPS (TTM)
$-0.57
EPS (Fwd)
$0.65
ROE
2.8%
ROA
3.7%
Cash
$182.3M
Total Debt
$4.04B
Free CF
$199.1M
52W Change
-28.4%
Annual Financials
Cash vs Debt
The company holds $182.3M in cash, though total debt stands at $4.04B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $199.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 2.8%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 3.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $2.54B (2022) to $3.31B (2025), reflecting a 30% increase over the period.
With a beta above 1.5, SGRY tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing SGRY.